International Journal of Current Research and Review
ISSN: 2231-2196 (Print)ISSN: 0975-5241 (Online)
Bootstrap Slider

Indexed and Abstracted in: Crossref, CAS Abstracts, Publons, Google Scholar, Open J-Gate, ROAD, Indian Citation Index (ICI), ResearchGATE, Ulrich's Periodicals Directory, WorldCat (World's largest network of library content and services)

Search Articles

Track manuscript

Full Html

IJCRR - 13(21), November, 2021

Pages: 65-72

Date of Publication: 09-Nov-2021

Print Article   Download XML  Download PDF

Synthesis and in vitro Antibacterial, Antitubercular and Cytotoxicity Evaluation of Lomefloxacin Derivatives

Author: Gurunani Gulshan, Agrawal Kapil, Walde Sheelpriya, Ittadwar Abhay

Category: Healthcare

Abstract:Introduction: The fluoroquinolones antibacterial agents are one of the fastest growing groups of drugs in recent years. The various side chains on it can be altered and the resulting analogues are evaluated for their anti-microbial and antitubercular properties. Most of these agents are substituted at the 7 positions by nitrogen heterocycles. Lomefloxacin at C-7, which represents a site amenable to significant modification. Objective: Based on evidence of research results and in search of new bioactive molecules in the fluoroquinolones, a of Nsubstituted piperazinyl quinolones have been designed, synthesized, characterized and evaluated for their antibacterial activity and antitubercular activity. Method: A series of 2-((5-chloro-1, 3, 4-thiadiazol-2yl) thio)-1-(4-subs.) ethanone (4a\?4j)were prepared by diazotization of amines (3a-3j) in concentrated HCl in the presence of Cu-powder. The reaction of(4a-4j) with piperazinyl quinolone (lomefloxacin) in DMF yield (5a-5j). The synthesized compounds were evaluated against some Gram-positive and Gram-negative bacterias and antitubercular activity against Mtb WT H37Rv. Result: The structure of the synthesized compound was confirmed by their IR, 1HNMR, data. The antibacterial data revealed that all substituted derivatives (5a to 5j), are found to be least active against Gram-positive and Gram-negative organisms. Among all of the tested compounds,5b(Lomefloxacin derivative) exhibited excellent antitubercular activity against Mtb WT H37Rv (MIC0.8 µg/ml) which is comparable to that of standard. (MIC 0.8 µg/ml) Conclusion: Although the nature of the C-7 substituent is known to enhance quinolone activity in bacteria but results of the present study reveal that the synthesized derivative shows significant antitubercular property but poor antibacterial activity.

Keywords: Antibacterial activity, Antitubercular activity, Fluoroquinolone, Lomefloxacin, N-piperazinyl quinolone, Synthesis

Full Text:


Fluoroquinolones, a major class of antibiotics, are under clinical development. The antibacterial activity of Fluoroquinolones is due to the inhibition of bacterial enzymes; DNA-gyrase and topoisomerase IV. They have potent activity, rapid bactericidal effects, and a low prevalence of resistance development.1The fluoroquinolones exert certain adverse effects, have restricted activity against Grampositivepathogens and methicillin-resistant Staphylococcus aureus (MRSA).2Therefore, there is a need of synthesizing novel quinolones with better activity profile, pharmacokinetics, and acceptability, to overcome the limitations of existing drugs.3 Most of the quinolone antibacterial research has been focused on substitution at the C-7  as it is the most adaptable site for chemical change.C-7 position is an area that determines potency and target preference and also controls the pharmacokinetic properties of the drugs, with basic nitrogen.4-6The most commonly found substitution at the C-7 position is a five- or six-membered ring. For example, aminopyrrolidine substituent at C-7 in trovafloxacinandgemifloxacinandPiperazine substitution at the C-7 position in norfloxacin, ciprofloxacin, pefloxacin, pefloxacin, ofloxacin, amifloxacin, fleroxacin, lomefloxacin, sparfloxacin, difloxacin, enoxacin, enrofloxacin, levofloxacin, marbofloxacin, and orbifloxacin which has triggered a wide range of clinically useful fluoroquinolone antibacterial agents.7-17(Figure 1) The site near the C-7 substituent is regarded as the domain for drug–enzyme interaction and the cell permeability.18-21 The piperazine moiety of 7-piperazinyl quinolones possesses enough structural flexibility to allow product optimization. In the present study, we have aimed to achieve a better antimicrobial profile at a lower concentration, by preparing [(7-(4--(5-substituted-benzoylthio)-1,3,4-thiadiazol-2-yl)-3-methylpiperazine-1-yl)-1-ethyl-6,8-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid](5a to 5j) derivatives and have been evaluated for its in vitro anti-bacterial and anti-tubercular effect. (Figure 2).

Materials and Methods


All the chemicals, reagents, and solvents used in this research were bought from E Merck Ltd, Loba chemicals Ltd, Sigma-Aldrich Ltd., Spectrochem Ltd., Hi-media, and Rankem Chemicals Ltd. Mumbai, India. Solvents used were dried and purified as and when required. The melting points reported were uncorrected and were determined in open capillaries using Thiele's melting point apparatus and measured in (°C). The yields of synthesized compounds were mentioned in tables along with respective physical constants. The FT-IR spectra were obtained Shimadzu FTIR spectrophotometer and values were measured in cm−1(potassium bromide disks). 1HNMR and 13C NMR were recorded at 400MHz and 100MHz respectively on a Bruker AM spectrometer, IISc Bangalore, and chemical shifts are expressed as δ (ppm) with tetramethylsilane as an internal standard. The FAB / EIMS mass spectra were recorded on Autospec Mass spectrometer, IICT, Hyderabad.


General Procedure for Synthesis of 2(a–j) (Figure 3)

Synthesis of substituted/unsubstituted phenacyl bromide 2(a–j)

0.1 mol of substituted/un-substituted acetophenones 1(a–j) were taken in the two-necked round bottom flask, suitable anhydrous solvents (ether, acetone, methanol, chloroform) was added with anhydrous AlCl3. The reaction condition was kept up either in cold or at room temperature and bromine (0.09mol) was added with stirring. Mixtures 2(a–j) were acquired as colourless to brown to shining crystals. The product was washed twice with appropriate solvents and recrystallized from methanol to get lachrymatory crystals.22-23 Liquefying point ranges of 2a–j; R = H, Cl, Br, F, NO2, CH3, OCH3,  NH2, OH, C6H5; 48-50°, 90–92°, 110–112°, 46-48, 96–98°, 52–54°,  72–74°, 80–84°, 102-104, 98-102 respectively (50–74 %).

General Procedure for Synthesis of3(a–j). (Figure 3)

Synthesis of 2-((amino-1,3,4-thiadiazol-2yl)thio)-1-(4-subst.) ethanone  3 (a–j).

The 2-amino-5- mercapto-1,3,4-thiadiazole (0.1mol) was suspended in 15 ml of water and 80% potassium hydroxide (0.1 mol) was added. This solution was de-colorized with activated charcoal, followed by the addition of 32 mL of ethanol and stirred rapidly with 2 (a–j) (0.1mol). The reaction mixture was cooled for 40 minutes and it added 200 mL of cold water. It is then filtered to obtain the solid product and washed with ether and water. The 3(a–j) were obtained (Scheme 1), with 54–68% yield and melting point (80–108oC). 24-25

General Procedure for Synthesis of4(a–j). (Figure 3)

Procedure for Synthesis of 2-((5-chloro-1, 3, 4-thiadiazol-2yl) thio)-1-(4-subs.)ethanone4 (a–j)

Triturated 2-((amino-1,3,4-thiadiazol-2yl) thio)-1-(4-subs.) ethanone  3(a–j) (30 mmol) with sodium nitrite (60 mmol). The triturate was introduced in the ice-cooled (0–5oC) mixture of 15 ml water and 30 ml concentrated HCl with stirring in the presence of copper powder. The product was refluxed for 1 hour at 750C and cool. Then the mixture was extracted thrice with dry chloroform (75 ml). The combined extracts of chloroform were washed with a sodium bicarbonate solution. Then the solution was dried over sodium sulphate followed by evaporation under reduced pressure. Finally,  recrystallization of the product was done using ethanol to yield 2-((5-chloro-1, 3, 4-thiadiazol-2yl)thio)-1-(4-subst) ethanone 4 (a–j) (Scheme 1). The compound was purified by column chromatography with methanol: chloroform (1:9) as mobile phase26, m.p. 85–110oC (48–60%).

General Procedure for Synthesis of 5(a–j). (Figure 3)

Synthesis of 1-subst.-6-fluoro-8-subst.-7-(3-subst.-4-(5-subst.((2-oxo-2-(p-subst.)ethyl)thio)-1,3,4-thiadiazol-2-yl)piperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid  5(a–j).

A combination of equimolar quantities of compound 2-((5-chloro-1, 3, 4-thiadiazol-2yl)thio)-1-(4-subs.)ethanone4(a–j) and piperazinyl fluoroquinolone (sparfloxacin), along with sodium-bicarbonate in 10 ml dimethyl-formamide was refluxed on an oil bath at 140–160oC for hrs. After cooling the reaction mixture, 10ml of cold water was added to it. The precipitated product was filtered and washed with water. The product was then subjected to recrystallization using a blend of dimethylformamide and water to yield (5a-j) compounds.27-28 (Scheme 1). The Physicochemical results are shown in (Table 1)

Antibacterial Activity

Preliminary in vitro antibacterial activity was employed by the broth micro-dilution technique.  Antibacterial Activity was examined against two Gram-negative microorganisms, Pseudomonas aeruginosa and Escherichia coli, and two Gram-positive microorganisms, Staphylococcus aureus and Bacillus subtilis. The test compounds and reference drugs (Sparfloxacin and Rifampicin) were prepared in Mueller-Hinton agar medium by two-fold serial dilutions. The required concentrations of 0.5, 1.0, 2.5, 5.0, 7.5, 10.0, 12.5, 15.0, 17.5, and 20.0 µg/ml was obtain by Progressive double dilutions with agar.  The Petri plates were inoculated with 1–5 × 104 colonies forming units (CFU/ml) and incubated at 370C for 18 hours.29The results are presented in (Table 2).

Anti-tubercular Activity

In vitro screening for anti-mycobacterial was performed by utilizing M. tuberculosis virulent H37Rv strain. The broth dilution assay for each drug for determination of  MIC was determined by using the frozen culture of Middlebrook 7H9 broth supplemented with 10% ADC (albumin dextrose catalase) and 0.2% glycerol. It is used as inoculum with dilution in broth to 2 × 105CFU/ml. In the assay, for the accommodation of compounds U-tubes were used in 0.1, 0.5, 1.5, 2.5, 05, 7.5, 10, 12.5, 15, 17.5 and 20 mg/ml dilutions.30-31 The results are presented in (Table 2).

In-vitro cytotoxic study

Estimation of cell viability

Conversion of MTT [(3-(4,5-dimethyl thiazol-2-yl)-2,5-diphenyl tetrasodium bromide)] to dark blue formazan crystals due to the presence of living cells, was employed for estimation of cell viability. Colourimetric analysis was used for the estimation of MTT cleaved to the viable cells.The solution of compounds under investigation in DMSO was diluted to achieve test concentrations. The DMSO content was maintained below 0.1% in all the aliquots under investigation. The cultured Hep-G2 normal liver-cell lines were added in plates with 96 wells and then preserved with variable dilutions of investigational compounds in DMSO, at 37oC in a carbon dioxide incubator for four days. Further, the MTT reagent was instilled into the wells and incubated for four hours, and then the dark blue formazan developed was allowed to dissolve in DMSO and the colourimetric absorbance was read at 550 nm. The IC50value was estimated by graph plotted between percentage cells inhibited versus concentrations.32 The findings are provided in (Table 2).


Spectral Data of synthesized compound

1-ethyl-6,8-difluoro-7-(3-methyl-4-(5-((2-oxo-2-phenylethyl)thio)-1,3,4-thiadiazol-2-yl)piperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (5a)

IR (KBr) cm-1: 3422(carboxylic, O-H str.), 2943(Ar. C-H str.), 2856(Ali. CH2, C-H str.), 1716(carboxylic, C=O str.), 1642(ketonic, C=O str.), 1588(Imine, C=N str.), 1320(ethylic, C-H str.); 1H-NMR (DMSO-?6) ?ppm: 12.52(s, carboxylic, 1H, OH), 9.02(s, 1H, H2-quinoline), 7.56-7.94(m, 5H, Ar.), 7.58(s, 1H, H5-quinoline), 4.92(s, 2H, CH2), 4.64(q, 2H, NCH2CH3), 2.92-3.50(m, 7H, piperazinyl), 1.38(t, 3H, NCH2CH3), 1.29 (s, 3H, piperazinyl CH3). 

7-(4-(5-((2-(4-chlorophenyl)-2-oxoethyl)thio)-1,3,4-thiadiazol-2-yl)-3-methylpiperazin-1-yl)-1-ethyl-6,8-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (5b)

IR (KBr) cm-1: 3445(carboxylic, O-H str.), 3005(Ar. C–H str.), 2852(Ali. CH2, C-H str.), 1725(carboxylic, C=O str.), 1656(ketonic, C=O str.), 1583(Imine, C=N str.), 1307(ethylic, C-H str.); 1H-NMR (DMSO-?6) ?ppm: 12.55(s, carboxylic, 1H, OH), 8.91(s, 1H, H2-quinoline), 7.60-7.92(m, 4H, Ar.), 7.42(s, 1H, H5-quinoline), 4.84(s, 2H, CH2), 4.57(q, 2H, NCH2CH3), 2.94-3.47(m, 7H, piperazinyl), 1.46(t, 3H, NCH2CH3), 1.33(s, 3H, piperazinyl CH3); 13C-NMR (DMSO-?6) ?ppm: 198, 180, 161, 158, 148, 144, 130, 118, 110, 68, 40, 18; MS: m/z = 619 [M+];CHN calcd;C27H24ClF2N5O4S2;C, 52.30; H, 3.90; N, 11.29; Found C, 52.34; H, 3.90; N, 11.30.

7-(4-(5-((2-(4-bromophenyl)-2-oxoethyl)thio)-1,3,4-thiadiazol-2-yl)-3-methylpiperazin-1-yl)-1-ethyl-6,8-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (5c)

IR (KBr) cm-1: 3444(carboxylic, O-H str.), 3009(Ar. C-H str.), 2850(Ali. CH2, C-H str.), 1728(carboxylic, C=O str.),  1625(ketonic, C=O str.), 1554(Imine,  C=N str.), 1310(ethylic, C-H str.); 1H-NMR (DMSO-?6) ?ppm: 12.58(s, carboxylic, 1H, OH), 8.93(s, 1H, H2-quinoline), 7.61-7.94(m, 4H, Ar.), 7.44(s, 1H, H5-quinoline), 4.80(s, 2H, CH2), 4.59(q, 2H, NCH2CH3), 2.93-3.48(m, 7H, piperazinyl), 1.48(t, 3H, NCH2CH3), 1.31(s, 3H, piperazinyl, CH3); 13C-NMR (DMSO-?6) ?ppm: 199, 181, 165, 160, 149, 128, 120, 108, 70, 42, 17.

5.4 7-(4-(5-((2-(4-fluorophenyl)-2-oxoethyl)thio)-1,3,4-thiadiazol-2-yl)-3-methylpiperazin-1-yl)-1-ethyl-6,8-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (5d)

IR (KBr) cm-1: 3454(carboxylic, O-H str.), 2926(Ar. C-H str.), 2853(Ali. CH2, C-H str.), 1726(carboxylic, C=O str.),  1658(ketonic, C=O str.), 1584(Imine, C=N str.), 1327(ethylic, C-H str.); 1H-NMR (DMSO-?6) ?ppm: 12.68(s, carboxylic, 1H, OH), 8.94(s, 1H, H2-quinoline), 7.98-8.02(m, 4H, Ar.), 7.78(s, 1H, H5-quinoline), 4.59(s, 2H, CH2), 4.42(q, 2H, NCH2CH3), 2.50-3.50(m, 7H, piperazinyl), 1.48(t, 3H, NCH2CH3), 1.25(s, 3H, piperazinyl CH3); 13C-NMR(DMSO-?6) ?ppm: 197, 173, 148, 133, 117, 107, 98, 74, 48, 38, 37; MS: m/z = 602 [M+]; CHN calcd; C27H24F3N5O4S2; C, 53.72; H, 4.01; N, 11.60; Found C, 54.12; H, 3.98; N, 11.94.

7-(4-(5-((2-(4-nitrophenyl)-2-oxoethyl)thio)-1,3,4-thiadiazol-2-yl)-3-methylpiperazin-1-yl)-1-ethyl-6,8-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (5e)

IR (KBr) cm-1: 3441(s, carboxylic, O-H str.), 3006(Ar. C-H str.), 1374(Ali. CH2, C-H str.), 1728(carboxylic, C=O str.), 1624(ketonic, C=O str.), 1547(Imine, C=N str.), 1311(ethylic, C-H str.); 1H-NMR (DMSO-?6) ?ppm: 12.56(s, 1H, carboxylic, OH), 8.92(s, 1H, H2-quinoline), 7.74-7.92(m, 4H, Ar.), 7.47(s, 1H, H5-quinoline), 4.83(s, 2H, CH2), 4.65(q, 2H, NCH2CH3), 2.92-3.47(m, 7H, piperazinyl), 1.47(t, 3H, NCH2CH3), 1.38(s, 3H, piperazinyl CH3); 13C-NMR (DMSO-?6) ?ppm: 192, 183, 165, 155, 147, 138, 129, 113, 74, 47, 11; MS : m/z = 630 [M+];CHN calcd;C27H24F2N6O6S2;C, 51.42; H, 3.84; N, 13.33; Found C, 51.40; H, 3.85; N, 13.30.

1-ethyl-6,8-difluoro-7-(3-methyl-4-(5-((2-oxo-2-(p-tolyl)ethyl)thio)-1,3,4-thiadiazol-2-yl)piperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (5f)

IR (KBr) cm-1: 3427(s, carboxylic, O-H str.), 2934(Ar. C-H str.), 2854(Ali. CH2, C-H str.), 1710(carboxylic, C=O str.),  1623(ketonic, C=O str.), 1576(Imine, C=N str.), 1298(ethylic, C-H str.); 1H-NMR (DMSO-?6) ?ppm: 12.06(s, 1H, carboxylic, OH), 8.84(s, 1H, H2-quinoline), 7.54-7.68(m, 4H, Ar.), 7.38(s, 1H, H5-quinoline), 4.64(s, 2H, CH2), 4.32(q, 2H, NCH2CH3), 2.83-3.27(m, 7H, piperazinyl), 2.37(s, 3H, tolyl), 1.32(t, 3H, NCH2CH3), 1.19(s, 3H, piperazinyl CH3); 13C- NMR (DMSO-?6) ?ppm: 188, 179, 158, 147, 135, 128, 116, 108, 68, 35, 16, 7.

7-(4-(5-((2-(4-methoxyphenyl)-2-oxoethyl)thio)-1,3,4-thiadiazol-2-yl)-3-methylpiperazin-1-yl)-1-ethyl-6,8-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (5g)

IR (KBr) cm-1: 3445(carboxylic, O-H str.), 3011(Ar. C-H str.), 2851(Ali. CH2, C-H str.), 1728(carboxylic, C=O str.), 1634(ketonic, C=O str.), 1581(Imine, C=N str.), 1310(ethylic, C-H str.); 1H-NMR (DMSO-?6) ?ppm: 12.83(s, carboxylic, 1H, OH), 9.04(s, 1H, H2-quinoline), 7.14-7.98(m, 4H, Ar.), 7.84(s, 1H, H5-quinoline), 4.71(s, 2H, CH2), 4.37(q, 2H, NCH2CH3), 3.83(s, 3H, methoxyl), 2.92-3.67(m, 7H, piperazinyl), 1.31(t, 3H, NCH2CH3), 1.11(s, 3H, piperazinyl CH3); 13C- NMR (DMSO-?6) ?ppm: 191, 184, 168, 156, 138, 129, 112, 108, 60, 38, 18, 11; MS: m/z = 617 [M+1];CHN calcd;C28H27F2N5O5S2;C, 54.62; H, 4.42; N, 11.38; Found C, 54.64; H, 4.40; N, 11.37.

7-(4-(5-((2-(4-aminophenyl)-2-oxoethyl)thio)-1,3,4-thiadiazol-2-yl)-3-methylpiperazin-1-yl)-1-ethyl-6,8-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (5h)

IR (KBr) cm-1: 3452(carboxylic, O-H str.), 3367(Ar. NH2, N-H str.), 3027(Ar. C-H str.), 2851(Ali. CH2, C-H str.), 1736(carboxylic, C=O str.), 1628(ketonic, C=O str.), 1580(Imine, C=N str.), 1327(ethylic, C-H str.); 1H-NMR (DMSO-?6) ?ppm: 12.88(s, carboxylic, 1H, OH), 9.12(s, 1H, H2-quinoline), 7.86(s, 1H, H5-quinoline), 6.83-7.72(m, 4H, Ar.), 6.31(s, 2H, Ar. NH2), 4.72(s, 2H, CH2), 4.32(q, 2H, NCH2CH3), 3.02-3.62(m, 7H, piperazinyl), 1.29(t, 3H, NCH2CH3), 1.14(s, 3H, piperazinyl CH3); 13C- NMR (DMSO-?6) ?ppm: 197, 187, 172, 151, 133, 123, 117, 107, 67, 35, 16; MS: m/z = 601 [M+1];CHN calcd;C27H26F2N6O4S2; C, 53.99; H, 4.36; N, 13.99; Found C, 54.02; H, 4.37; N, 13.98.


  1. Wolfson JS, Hooper DC. The Fluoroquinolones: Structures, Mechanisms of Action and Resistance, and Spectra of Activity In-Vitro. AntimicrobagentsandChemother., 1985 Oct 28(4); 581-6.

  2. Ball P. Bacterial resistance to fluoroquinolones: Lessons to be learned’, Infection, 1994; 22(2 Supplement).

  3. Domagala JM.1-Substituted 7-[3-[(Ethylamino)methyl]-1-pyrrolidinyl]-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acids. New Quantitative Structure-Activity Relationships at N1 for the Quinolone Antibacterials’, J. Med Chem., 1988; 31(5):991–1001.

  4. Chu DT, Fernandes PB, Claiborne AK,  Pernet AG.  Synthesis and structure-activity relationships of novel arylfluoroquinolone antibacterial agents. J. Med Chem.,1985; 28(11):1558–64

  5. Rosen  T. Mechanism of inhibition of DNA gyrase by quinolone antibacterials: A cooperative drug-DNA binding model. Biochem. 1989; 28(9):3886–94.

  6. Sarro A,  Sarro G. Adverse Reactions to Fluoroquinolones. An Overview on Mechanistic Aspects. Curr Med Chem. 2001; 8(4):371–84.

  7. Anderson V, Osheroff N. Type II Topoisomerases as Targets for Quinolone Antibacterials Turning Dr. Jekyll into Mr. Hyde. Curr Pharm Design. 2001;7(5):337–53..

  8. Koga H,  Itoh A,  Murayama S,  Suzue S,  IrikuraT. Structure-Activity Relationships Of Antibacterial 6, 7-and 7, 8-Disubstituted 1-Alkyl-1, 4-Dihydro-4-Oxoquinoline-3-Carboxylic Acids. J. Med. Chem, 1980; 23(12):1358–63.

  9. Hagihara M, Kashiwase H, Katsube T, Kimura T, Komai T, Momota K, Shimada K.  Synthesis and anti-HIV activity of arylpiperazinyl fluoroquinolones: A new class of anti-HIV agents. Bioorg & Med. Chem. Letters,1999;9(21):3063–68.

  10. Domagala JM, Hanna LD, Heifetz CL, Hutt MP, Mich TF, Sanchez J. New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay. J. Med. Chem., 1986;29(3):394–404.

  11. Kondo H, Sakamoto F, Kodera Y,  Tsukamoto G.  Studies on prodrugs. 5. Synthesis and antimicrobial activity of N-(oxoalkyl)norfloxacin derivatives. J Med. Chem. 1986;29(10):2020–24.

  12. Fang KC, Chen YL, Sheu JY, Wang TC, Tzeng CC. Synthesis, Antibacterial, and Cytotoxic Evaluation of Certain 7-Substituted Norfloxacin Derivatives. J. Med. Chem., 2000;43(20):3809–12.

  13. Gootz TD, McGuirk PR, Moynihan MS,  Haskell SL, Placement of alkyl substituents on the C-7 piperazine ring of fluoroquinolones: dramatic differential effects on mammalian topoisomerase II and DNA gyrase. Antimicrob Age Chemother., 1994;38(1):130–33.

  14. Pandeya, S. N., Sriram, D., Nath, G., & De Clercq, E., Synthesis, antibacterial, antifungal and anti-HIV activities of norfloxacin Mannich bases. Euro J. Med. Chem, 2000;35(2):249–55

  15. Chu, D. T. W., Fernandes, P. B., Maleczka, R. E., Nordeen, C. W., & Pernet, A. G., Synthesis and structure-activity relationship of 1-aryl-6,8-fluoroquinolone antibacterial agents. J. Med. Chem., 1987;30(3):504–09.

  16. Shen, L. L., & Pernet, A. G., Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: the target of the drugs is DNA. Proc Natl Acad Sci U S A, 1985; 82(2):307–11.

  17. L. L. Shen, W E. Kohlbrenner, D. W. J. Baranowski; Mechanism of quinolone inhibition of DNA gyrase: Appearance of unique norfloxacin binding sites in enzyme-DNA complexes; J Biol Chem., 1989 Feb;  264(5):2973-78.

  18. Shen, L. L., Baranowski, J., & Pernet, A. G., Mechanism of inhibition of DNA gyrase by quinolone antibacterials: specificity and cooperativity of drug binding to DNA. Biochemistry, 1989; 28(9):3879–85.

  19. Klopman, G., Macina, O. T., Levinson, M. E., & Rosenkranz, H. S., Computer automated structure evaluation of quinolone antibacterial agents. Antimicrob agents and Chemother., 1987;31(11):1831–40.

  20. Russo, F.; Santagati, M, Synthesis and evaluation of the antibacterial activity of benzothiazole derivatives of 1,3,4- thiadiazole and imidazo/2,1-b,1,3,4-thiadiazole Il Farmaco Sci., 1976; 31:41-48.

  21. Tsotinis A, Varvaresou A, Calogeropoulou T, Sinatra-Papastaikoudi T, Tiligada A; Synthesis and antimicrobial evaluation of indole containing derivatives of 1,3,4-thiadiazole, 1,2,4-triazole and their open-chain counterparts, Arzneimittelforschung, 01 Mar 1997; 47(3):307-10.

  22. Organic Syntheses, Coll, R. M. Cowper, L. H. Davidson, and A. H. Blatt, Eds., vol. 2, pp. 480–481, John Wiley & Sons, NewYork, NY, USA, 1943.

  23. Organic Syntheses. Coll, G. H. Coleman, G. E. Honeywell, and A. H. Blatt, Eds., vol. 2, pp. 443–445, John Wiley & Sons, New York, NY, USA, 1943.

  24. Dogan H.N, Duran A, Rollas S, Sener G, Uysal MK,  Gülen D. Synthesis of new 2,5-Disubstituted-1,3,4-thiadiazoles and preliminary evaluation of anticonvulsant and antimicrobial activities. Bioorg  Med Chem., 2002; 10(9):2893–98.

  25. Varvaresou A, Sinatra-Papastaikoudi T, Tsotinis A, Tsantili-Kakoulidou A,  Vamvakides, A.  Synthesis, lipophilicity and biological evaluation of indole-containing derivatives of 1,3,4-thiadiazole and 1,2,4-triazole. Il Farmaco, 1998;53(5):320–26.

  26. Foroumadi A, Rineh A, Emami S, Siavoshi F, Massarra S, Safari al. Synthesis and anti-Helicobacter pylori activity of 5-(nitroaryl)-1,3,4-thiadiazoles with certain sulfur-containing alkyl side chain.Bioorg. Med Chem Lett. 2008; 18(11):3315-20.

  27. Foroumadi A. Emami S, Pournourmohammadi S, Kharazmi A, Shafiee A. Synthesis and in vitro leishmanicidal activity of 2-(1-methyl-5-nitro-1H-imidazol-2-yl)-5-substituted-1, 3, 4-thiadiazole derivatives. Eur J Med Chem. 2005; 40(12):1346-50.

  28. Foroumadi A, Mansouri S, Kiani Z, Rahmani A. Synthesis and in vitro antibacterial evaluation of N-[5-(5-nitro-2-thienyl)-1, 3, 4-thiadiazole-2-yl] piperazinyl quinolones. Eur. J Med Chem. 2003; 38(9):851-54.

  29. GotoS, Sakamoto H, Ogawa M. Bactericidal activity of cefazolin, cefoxitin, and cefmetazole against Escherichia coli and Klebsiella pneumonia. Chemother. 1982; 28(1):18–25.

  30. SulingWJ, SeitzLE& Pathak V. Antimycobacterial activities of 2,4-diamino-5-deazapteridine derivatives and effects on mycobacterial dihydrofolate reductase, Antimicrob agent Chemother. 2000;44(10):2784–2793.

  31. Yajko DM, MadejJJ& Lancaster MV. Colorimetric method for determining MICs of antimicrobial agents for Mycobacterium tuberculosis. J Clin Micro. 1995; 33(9):2324–27.

  32. Sriram D, Yogeeswari P,  ReddySP. Synthesis of pyrazinamide Mannich bases and its antitubercular properties. Bioorg Med Chem Letters, 2006;16(8):2113–16.

  33. Morrison RT, Boyd RN. Organic Chemistry, Pearson Education, New Delhi, India:2004.

  34. Agrawal KM,  Talele GS. Synthesis and antibacterial, antimycobacterial and docking studies of novel N-piperazinyl fluoroquinolones. Med.Chem Res. 2013; 22(2):818–31.


Dr. Pramod Kumar Manjhi joined Editor-in-Chief since July 2021 onwards

COPE guidelines for Reviewers

SCOPUS indexing: 2014, 2019 to 2021

Awards, Research and Publication incentive Schemes by IJCRR

Best Article Award: 

One article from every issue is selected for the ‘Best Article Award’. Authors of selected ‘Best Article’ are rewarded with a certificate. IJCRR Editorial Board members select one ‘Best Article’ from the published issue based on originality, novelty, social usefulness of the work. The corresponding author of selected ‘Best Article Award’ is communicated and information of award is displayed on IJCRR’s website. Drop a mail to for more details.

Women Researcher Award:

This award is instituted to encourage women researchers to publish her work in IJCRR. Women researcher, who intends to publish her research work in IJCRR as the first author is eligible to apply for this award. Editorial Board members decide on the selection of women researchers based on the originality, novelty, and social contribution of the research work. The corresponding author of the selected manuscript is communicated and information is displayed on IJCRR’s website. Under this award selected women, the author is eligible for publication incentives. Drop a mail to for more details.

Emerging Researcher Award:

‘Emerging Researcher Award’ is instituted to encourage student researchers to publish their work in IJCRR. Student researchers, who intend to publish their research or review work in IJCRR as the first author are eligible to apply for this award. Editorial Board members decide on the selection of student researchers for the said award based on originality, novelty, and social applicability of the research work. Under this award selected student researcher is eligible for publication incentives. Drop a mail to for more details.

Best Article Award

A Study by Humaira Tahir et al. entitled "Comparison of First Analgesic Demand after Major Surgeries of Obstetrics and Gynecology between Pre-Emptive Versus Intra-Operative Groups by Using Intravenous Paracetamol: A Cross-Sectional Study" is awarded Best Article for Vol 14 issue 14
A Study by Monica K. entitled "Risk Predictors for Lymphoma Development in Sjogren Syndrome - A Systematic Review" is awarded Best Article for Vol 14 issue 13
A Study by Mokhtar M Sh et al. entitled "Prevalence of Hospital Mortality of Critically Ill Elderly Patients" is awarded Best Article for Vol 14 issue 12
A Study by Vidya S. Bhat et al. entitled "Effect of an Indigenous Cleanser on the Microbial Biofilm on Acrylic Denture Base - A Pilot Study" is awarded Best Article for Vol 14 issue 11
A Study by Pandya S. et al. entitled "Acute and 28-Day Repeated Dose Subacute Toxicological Evaluation of Coroprotect Tablet in Rodents" is awarded Best Article for Vol 14 issue 10
A Study by Muhammad Zaki et al. entitled "Effect of Hemoglobin Level on the Severity of Acute Bronchiolitis in Children: A Case-Control Study" is awarded Best Article for Vol 14 issue 09
A Study by Vinita S & Ayushi S entitled "Role of Colour Doppler and Transvaginal Sonography for diagnosis of endometrial pathology in women presenting with Abnormal Uterine Bleeding" is awarded Best Article for Vol 14 issue 08
A Study by Prabhu A et al. entitled "Awareness of Common Eye Conditions among the ASHA (Accredited Social Health Activist) Workers in the Rural Communities of Udupi District- A Pilot Study" is awarded Best Article for Vol 14 issue 07
A Study by Divya MP et al. entitled "Non-Echoplanar Diffusion-Weighted Imaging and 3D Fiesta Magnetic Resonance Imaging Sequences with High Resolution Computed Tomography Temporal Bone in Assessment and Predicting the Outcome of Chronic Suppurative Otitis Media with Cholesteatoma" is awarded Best Article for Vol 14 issue 06
A Study by Zahoor Illahi Soomro et al. entitled "Functional Outcomes of Fracture Distal Radius after Fixation with Two Different Plates: A Retrospective Comparative Study" is awarded Best Article for Vol 14 issue 05
A Study by Ajai KG & Athira KN entitled "Patients’ Gratification Towards Service Delivery Among Government Hospitals with Particular Orientation Towards Primary Health Centres" is awarded Best Article for Vol 14 issue 04
A Study by Mbungu Mulaila AP et al. entitled "Ovarian Pregnancy in Kindu City, D.R. Congo - A Case Report" is awarded Best Article for Vol 14 issue 03
A Study by Maryam MJ et al. entitled "Evaluation Serum Chemerin and Visfatin Levels with Rheumatoid Arthritis: Possible Diagnostic Biomarkers" is awarded Best Article for Vol 14 issue 02
A Study by Shanthan KR et al. entitled "Comparison of Ultrasound Guided Versus Nerve Stimulator Guided Technique of Supraclavicular Brachial Plexus Block in Patients Undergoing Upper Limb Surgeries" is awarded Best Article for Vol 14 issue 01
A Study by Amol Sanap et al. entitled "The Outcome of Coxofemoral Bypass Using Cemented Bipolar Hemiarthroplasty in the Treatment of Unstable Intertrochanteric Fracture of Femur in a Rural Setup" is awarded Best Article Award of Vol 13 issue 24
A Study by Manoj KP et al. entitled "A Randomized Comparative Clinical Trial to Know the Efficacy of Ultrasound-Guided Transversus Abdominis Plane Block Against Multimodal Analgesia for Postoperative Analgesia Following Caesarean Section" is awarded Best Article Award of Vol 13 issue 23
A Study by Karimova II et al. entitled "Changes in the Activity of Intestinal Carbohydrases in Alloxan-Induced Diabetic Rats and Their Correction with Prenalon" is awarded Best Article of Vol 13 issue 22
A Study by Ashish B Roge et al. entitled "Development, Validation of RP-HPLC Method and GC MS Analysis of Desloratadine HCL and It’s Degradation Products" is awarded Best Article of Vol 13 issue 21
A Study by Isha Gaurav et al. entitled "Association of ABO Blood Group with Oral Cancer and Precancer – A Case-control Study" is awarded Best Article for Vol 13 issue 20
A Study by Amr Y. Zakaria et al. entitled "Single Nucleotide Polymorphisms of ATP-Binding Cassette Gene(ABCC3 rs4793665) affect High Dose Methotrexate-Induced Nephrotoxicity in Children with Osteosarcoma" is awarded Best Article for Vol 13 issue 19
A Study by Kholis Ernawati et al. entitled "The Utilization of Mobile-Based Information Technology in the Management of Dengue Fever in the Community Year 2019-2020: Systematic Review" is awarded Best Article for Vol 13 issue 18
A Study by Bhat Asifa et al. entitled "Efficacy of Modified Carbapenem Inactivation Method for Carbapenemase Detection and Comparative Evaluation with Polymerase Chain Reaction for the Identification of Carbapenemase Producing Klebsiella pneumonia Isolates" is awarded Best Article for Vol 13 issue 17
A Study by Gupta R. et al. entitled "A Clinical Study of Paediatric Tracheostomy: Our Experience in a Tertiary Care Hospital in North India" is awarded Best Article for Vol 13 issue 16
A Study by Chandran Anand et al. entitled "A Prospective Study on Assessment of Quality of Life of Patients Receiving Sorafenib for Hepatocellular Carcinoma" is awarded Best article for Vol 13 issue 15
A Study by Rosa PS et al. entitled "Emotional State Due to the Covid – 19 Pandemic in People Residing in a Vulnerable Area in North Lima" is awarded Best Article for Vol 13 issue 14
A Study by Suvarna Sunder J et al. entitled "Endodontic Revascularization of Necrotic Permanent Anterior Tooth with Platelet Rich Fibrin, Platelet Rich Plasma, and Blood Clot - A Comparative Study" is awarded Best Article for Vol 13 issue 13
A Study by Mona Isam Eldin Osman et al. entitled "Psychological Impact and Risk Factors of Sexual Abuse on Sudanese Children in Khartoum State" is awarded Best Article for Vol 13 issue 12
A Study by Khaw Ming Sheng & Sathiapriya Ramiah entitled "Web Based Suicide Prevention Application for Patients Suffering from Depression" is awarded Best Article for Vol 13 issue 11
A Study by Purushottam S. G. et al. entitled "Development of Fenofibrate Solid Dispersions for the Plausible Aqueous Solubility Augmentation of this BCS Class-II Drug" is awarded Best article for Vol 13 issue 10
A Study by Kumar S. et al. entitled "A Study on Clinical Spectrum, Laboratory Profile, Complications and Outcome of Pediatric Scrub Typhus Patients Admitted to an Intensive Care Unit from a Tertiary Care Hospital from Eastern India" is awarded Best Article for Vol 13 issue 09
A Study by Mardhiah Kamaruddin et al. entitled "The Pattern of Creatinine Clearance in Gestational and Chronic Hypertension Women from the Third Trimester to 12 Weeks Postpartum" is awarded Best Article for Vol 13 issue 08
A Study by Sarmila G. B. et al. entitled "Study to Compare the Efficacy of Orally Administered Melatonin and Clonidine for Attenuation of Hemodynamic Response During Laryngoscopy and Endotracheal Intubation in Gastrointestinal Surgeries" is awarded Best Article for Vol 13 issue 07
A Study by M. Muthu Uma Maheswari et al. entitled "A Study on C-reactive Protein and Liver Function Tests in Laboratory RT-PCR Positive Covid-19 Patients in a Tertiary Care Centre – A Retrospective Study" is awarded Best Article of Vol 13 issue 06 Special issue Modern approaches for diagnosis of COVID-19 and current status of awareness
A Study by Gainneos PD et al. entitled "A Comparative Evaluation of the Levels of Salivary IgA in HIV Affected Children and the Children of the General Population within the Age Group of 9 – 12 Years – A Cross-Sectional Study" is awarded Best Article of Vol 13 issue 05 Special issue on Recent Advances in Dentistry for better Oral Health
A Study by Alkhansa Mahmoud et al. entitled "mRNA Expression of Somatostatin Receptors (1-5) in MCF7 and MDA-MB231 Breast Cancer Cells" is awarded Best Article of Vol 13 issue 06
A Study by Chen YY and Ghazali SRB entitled "Lifetime Trauma, posttraumatic stress disorder Symptoms and Early Adolescence Risk Factors for Poor Physical Health Outcome Among Malaysian Adolescents" is awarded Best Article of Vol 13 issue 04 Special issue on Current Updates in Plant Biology to Medicine to Healthcare Awareness in Malaysia
A Study by Kumari PM et al. entitled "Study to Evaluate the Adverse Drug Reactions in a Tertiary Care Teaching Hospital in Tamilnadu - A Cross-Sectional Study" is awarded Best Article for Vol 13 issue 05
A Study by Anu et al. entitled "Effectiveness of Cytological Scoring Systems for Evaluation of Breast Lesion Cytology with its Histopathological Correlation" is awarded Best Article of Vol 13 issue 04
A Study by Sharipov R. Kh. et al. entitled "Interaction of Correction of Lipid Peroxidation Disorders with Oxibral" is awarded Best Article of Vol 13 issue 03
A Study by Tarek Elwakil et al. entitled "Led Light Photobiomodulation Effect on Wound Healing Combined with Phenytoin in Mice Model" is awarded Best Article of Vol 13 issue 02
A Study by Mohita Ray et al. entitled "Accuracy of Intra-Operative Frozen Section Consultation of Gastrointestinal Biopsy Samples in Correlation with the Final Histopathological Diagnosis" is awarded Best Article for Vol 13 issue 01
A Study by Badritdinova MN et al. entitled "Peculiarities of a Pain in Patients with Ischemic Heart Disease in the Presence of Individual Combines of the Metabolic Syndrome" is awarded Best Article for Vol 12 issue 24
A Study by Sindhu Priya E S et al. entitled "Neuroprotective activity of Pyrazolone Derivatives Against Paraquat-induced Oxidative Stress and Locomotor Impairment in Drosophila melanogaster" is awarded Best Article for Vol 12 issue 23
A Study by Habiba Suhail et al. entitled "Effect of Majoon Murmakki in Dysmenorrhoea (Usre Tams): A Standard Controlled Clinical Study" is awarded Best Article for Vol 12 issue 22
A Study by Ghaffar UB et al. entitled "Correlation between Height and Foot Length in Saudi Population in Majmaah, Saudi Arabia" is awarded Best Article for Vol 12 issue 21
A Study by Siti Sarah Binti Maidin entitled "Sleep Well: Mobile Application to Address Sleeping Problems" is awarded Best Article for Vol 12 issue 20
A Study by Avijit Singh"Comparison of Post Operative Clinical Outcomes Between “Made in India” TTK Chitra Mechanical Heart Valve Versus St Jude Mechanical Heart Valve in Valve Replacement Surgery" is awarded Best Article for Vol 12 issue 19
A Study by Sonali Banerjee and Mary Mathews N. entitled "Exploring Quality of Life and Perceived Experiences Among Couples Undergoing Fertility Treatment in Western India: A Mixed Methodology" is awarded Best Article for Vol 12 issue 18
A Study by Jabbar Desai et al. entitled "Prevalence of Obstructive Airway Disease in Patients with Ischemic Heart Disease and Hypertension" is awarded Best Article for Vol 12 issue 17
A Study by Juna Byun et al. entitled "Study on Difference in Coronavirus-19 Related Anxiety between Face-to-face and Non-face-to-face Classes among University Students in South Korea" is awarded Best Article for Vol 12 issue 16
A Study by Sudha Ramachandra & Vinay Chavan entitled "Enhanced-Hybrid-Age Layered Population Structure (E-Hybrid-ALPS): A Genetic Algorithm with Adaptive Crossover for Molecular Docking Studies of Drug Discovery Process" is awarded Best article for Vol 12 issue 15
A Study by Varsha M. Shindhe et al. entitled "A Study on Effect of Smokeless Tobacco on Pulmonary Function Tests in Class IV Workers of USM-KLE (Universiti Sains Malaysia-Karnataka Lingayat Education Society) International Medical Programme, Belagavi" is awarded Best article of Vol 12 issue 14, July 2020
A study by Amruta Choudhary et al. entitled "Family Planning Knowledge, Attitude and Practice Among Women of Reproductive Age from Rural Area of Central India" is awarded Best Article for special issue "Modern Therapeutics Applications"
A study by Raunak Das entitled "Study of Cardiovascular Dysfunctions in Interstitial Lung Diseas epatients by Correlating the Levels of Serum NT PRO BNP and Microalbuminuria (Biomarkers of Cardiovascular Dysfunction) with Echocardiographic, Bronchoscopic and HighResolution Computed Tomography Findings of These ILD Patients" is awarded Best Article of Vol 12 issue 13 
A Study by Kannamani Ramasamy et al. entitled "COVID-19 Situation at Chennai City – Forecasting for the Better Pandemic Management" is awarded best article for  Vol 12 issue 12
A Study by Muhammet Lutfi SELCUK and Fatma entitled "Distinction of Gray and White Matter for Some Histological Staining Methods in New Zealand Rabbit's Brain" is awarded best article for  Vol 12 issue 11
A Study by Anamul Haq et al. entitled "Etiology of Abnormal Uterine Bleeding in Adolescents – Emphasis Upon Polycystic Ovarian Syndrome" is awarded best article for  Vol 12 issue 10
A Study by entitled "Estimation of Reference Interval of Serum Progesterone During Three Trimesters of Normal Pregnancy in a Tertiary Care Hospital of Kolkata" is awarded best article for  Vol 12 issue 09
A Study by Ilona Gracie De Souza & Pavan Kumar G. entitled "Effect of Releasing Myofascial Chain in Patients with Patellofemoral Pain Syndrome - A Randomized Clinical Trial" is awarded best article for  Vol 12 issue 08
A Study by Virendra Atam et. al. entitled "Clinical Profile and Short - Term Mortality Predictors in Acute Stroke with Emphasis on Stress Hyperglycemia and THRIVE Score : An Observational Study" is awarded best article for  Vol 12 issue 07
A Study by K. Krupashree et. al. entitled "Protective Effects of Picrorhizakurroa Against Fumonisin B1 Induced Hepatotoxicity in Mice" is awarded best article for issue Vol 10 issue 20
A study by Mithun K.P. et al "Larvicidal Activity of Crude Solanum Nigrum Leaf and Berries Extract Against Dengue Vector-Aedesaegypti" is awarded Best Article for Vol 10 issue 14 of IJCRR
A study by Asha Menon "Women in Child Care and Early Education: Truly Nontraditional Work" is awarded Best Article for Vol 10 issue 13
A study by Deep J. M. "Prevalence of Molar-Incisor Hypomineralization in 7-13 Years Old Children of Biratnagar, Nepal: A Cross Sectional Study" is awarded Best Article for Vol 10 issue 11 of IJCRR
A review by Chitra et al to analyse relation between Obesity and Type 2 diabetes is awarded 'Best Article' for Vol 10 issue 10 by IJCRR. 
A study by Karanpreet et al "Pregnancy Induced Hypertension: A Study on Its Multisystem Involvement" is given Best Paper Award for Vol 10 issue 09

List of Awardees

A Study by Ese Anibor et al. "Evaluation of Temporomandibular Joint Disorders Among Delta State University Students in Abraka, Nigeria" from Vol 13 issue 16 received Emerging Researcher Award

A Study by Alkhansa Mahmoud et al. entitled "mRNA Expression of Somatostatin Receptors (1-5) in MCF7 and MDA-MB231 Breast Cancer Cells" from Vol 13 issue 06 received Emerging Researcher Award

RSS feed

Indexed and Abstracted in

Antiplagiarism Policy: IJCRR strongly condemn and discourage practice of plagiarism. All received manuscripts have to pass through "Plagiarism Detection Software" test before Toto Macau forwarding for peer review. We consider "Plagiarism is a crime"

IJCRR Code of Conduct: To achieve a high standard of publication, we adopt Good Publishing Practices (updated in 2022) which are inspired by guidelines provided by Committee on Publication Ethics (COPE), Open Access Scholarly Publishers Association (OASPA) and International Committee of Medical Journal Editors (ICMJE)

Disclaimer: International Journal of Current Research and Review (IJCRR) provides platform for researchers to publish and discuss their original research and review work. IJCRR can not be held responsible for views, opinions and written statements of researchers published in this journal.


International Journal of Current Research and Review (IJCRR) provides platform for researchers to publish and discuss their original research and review work. IJCRR can not be held responsible for views, opinions and written statements of researchers published in this journal


148, IMSR Building, Ayurvedic Layout,
        Near NIT Complex, Sakkardara,
        Nagpur-24, Maharashtra State, India

Copyright © 2023 IJCRR. Specialized online journals by ubijournal .Website by Ubitech solutions